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Abstract-Thyrotropin-releasing hormonewas shown to exert potent ventilatory effects after 
centrat administration. These data, however, were derived from studies using anesthetized 
animal preparations. Since TRH elicits strong arousal reactions, the observed ventilatory 
effects of TRH under anesthesia may have been due to nonspecific reduction in the anesthetic 
state of the animals. ln order to clarify the extent to which the reversal of anesthesia may 
change ventilatory parameters after TRH application, we investigated the effect of TRH on 
Ventilation rate, relative tidal volume, relative respiratory minute volume, C02 production C02 
consumption, and locomotor activity in the conscious, unrestrained rat. 
lntracerebroventricular application of TRH induced a dose-dependent, sustained increase in 
ventilation rate, relative tidal volume, and relative respiratory minute volume of maximally 
128%, 890o/o, and 235%, respectively. ln addition, C02 production and 0 2 consumption were 
elevated by 4.6 and 11.7 fold, whiJe no significant changes in locomotor activity were 
observed. The results suggest that TRH stimulates ventilation by a mechanism independent 
of its analeptic properties. 
Introduction 
The tripeptide Glp-His-Pro-NH2 , thyrotropin-re-
leasing hormone (TRH), was the first hypothala-
mic, hypophysiotropic releasing factor to be 
characterized, marking the initial development of 
the field of neuroendocrinology ( 1). More recent 
evidence, however, revealed that immunoreactive 
TRH is not only confined to hypothalamic nuclei 
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involved in the regulation of hypophyseal thyro-
tropin release, but is widely distributed through-
out the central nervous system (CNS), including 
telencephalic and medullary structures (2, 3). 
Moreover, high affinity TRH receptors have been 
localized in various CNS sites ( 4) suggesting that 
TRH may participate in the mediation or modu-
lation of a variety of CNS functions under physio-
logical conditions. This hypothesis is further 
validated by the profound effects of TRH on 
behavioral and autonomic functions after central 
and peripheral administration in experimental 
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animals ( 5, 6, 7). In addition to its potent cardio-
vascular effects, including increases in arterial 
pressure and heart rate (5), TRH has been shown 
to increase ventilation in the anesthestized rat 
after intracerebroventricular (icv) application (6) 
or after microinjection into various brainstem 
structures (8). Moreover TRH was shown to 
induce rhythmic depolarisations of neurons in the 
respiratory division of the nucleus tractus solitarii 
(9). TRH may therefore play a significant role in 
the central regulation of ventilation. In most of 
these studies, however, the animals were anesthe-
tized with urethane (10, 11), halothane (6), or 
urethane-chloralose (12). Since the central appli-
cation of TRH potently reverses the effects of 
various centrally acting drugs, including several 
anesthetics such as barbiturates and ethanol (13, 
14), the arousal reaction produced by TRH appli-
cation (15) may reduce the anesthetic state of the 
animalleading to an increased respiratory reaction 
to surgical stress or fixation in a stereotaxic appara-
tus. In order to determine whether the effects of 
TRH on respiratory parameters observed in 
anesthetized rats were due to a specific stimulation 
of centrat ventilatory control mechanisms or 
rather to a generat arousal reaction leading to a 
reversal of the anesthetic state, we investigated 
ventilatory responses and LA after icv injections 
of TRH in the conscious unrestrained rat. 
Materials and Methods 
Male Sprague Dawley rats (375-395 g) were 
obtained from Taconic Farms (Germantown, NY) 
and housed at controlled temperature (22 °C) and 
12 h light cycle with free access to food and water. 
Stainless steel guide cannulas were implanted 
prior to the experiment ( coordinates: -0.8 mm ap, 
-1.2mm lat from bregma) under halothane 
anesthesia (2°/o in oxygen). The animals were 
allowed to recover for at least 12h. All exper-
iments were conducted between 8 a.m. and 6 p.m. 
Ventilatory parameters were quantified by 
means of the OXYMAX '85 system (Columbus 
Instr., Ohio) for measurements of Ventilation rate 
(f), relative tidal volume (rVT), 0 2 consumption, 
and co2 production. The animals were placed in 
transparent plexiglass chambers of 6.551 volume 
with a constant ftow of 21 of room air per min. 
Measurements were performed every 2min. 
NEUROPEPliDES 
Ventilation rate (f) and rVT were determined 
based on the frequency ( respirationslmin) and 
amplitude (arbitrary units) of pressure changes 
due to the ventilatory movements of the animal's 
thorax. The relative ventilatory minute volume 
(rVE) was then calculated as the arithmetical 
productoff and rVT. The 02 and C02 contents of 
the animal chambers were measured against a 
reference chamber with an equal room air flow of 2 
Vmin. Arithmetical differences between the 
reference and animal chambers were expressed as 
02 consumption and co2 production respectively. 
One hour after the statt of the experiment the 
animals (n = 5) received a control injection of 
artifical cerebraspinal fluid (CSF) and consecutive 
injections of 0.25, 1.25, 2.5, 25 and 50nmol of 
TRH (Bachern) in 10~1 of artificial CSF icv. 
lnjections were performed manually over 10-15s, 
using a 30 gaugeneedle (7 .5 mm length) connected 
to a 25 J.Ll Aarnilton syringe by PE-50 tubing. In 
parallel with the measurements of ventilatory 
mechanics and gases, the locomotor activity (LA) 
of the animals was monitored, using the Opto-
Varimex system (Columbus lnstr., Ohio). The 
estimation of locomotor activity is based on the 
interruption of infrared light beams caused by 
movements of the animal. The observation period 
after each injection Iasted lh. After the exper-
iment, the animals were sacrificed and the location 
of the icv injection was verified by dye application. 
Baseline conditions were determined after the 
injection of artifical CSF as means over the last 
10-20min of the respective observation period. 
Changes (Ö) off, rVT, rVE, Oz consumption, and 
C02 production were calculated using a 
spreadsheet program (Framework, Microsoft). 
Dose related effects were assessed by the calcula-
tion of approximate curve areas of the parameter 
chnges over the 1 h observation periods, using a 
trapezoidal method. 
Statistical evaluation was done according to 
Kruskal-Wallis followed by Mann-Whitney-U test 
(16). Unless otherwise stated, the results are 
expressed as means ± Standard error of the mean 
(S.E.M.) for the indicated number of animals. 
Results 
TRH icv caused a dose dependent sustained 
increase of f ( curve areas) to a maximum of 128°/o 
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Flg. 1 Effects of TRH on relative ventilatory minute volume 
(rVE, [respirations (R)], ventilatory rate {f, [R]), and relative 
tidal volume (rVT, [%]) after consecutive icv administration of 
0.25, 1.25, 2.5, 25 and 50nmoles in 10 J.l.l artificial CSF. Data are 
expressed as approximate curve areas of parameter changes 
over 1 h after each injection. • {p < 0.05) and •• (p < 0.01) 
denote statistical significance, when compared to vehicle 
(artificial CSF) injection (Kruskal-Wallis, n = 5). 
compared to vehicle control after the highest dose 
of 50nmol icv (p < 0.01, n = 5; Fig. 1). RVT was 
maximally stimulated (8. 9 fold) after the lowest 
dose of TRH (0.25nmol; p < 0.01). Increasing 
doses, however, reduced r V T to Ievels comparable 
to those seen ~fter artifical CSF icv (Fig. 1). 
Nevertheless, rVE was increased to a maximum of 
235°/o compared to vehicle alone after 1.25 nmol 
TRH icv (p < 0.01), but seemed to decrease 
somewhat after injection of higher doses (Fig. 1). 
The maximum effects of TRH on C02 production 
and 0 2 consumption were achieved after the 
1.25 nrnol dose with sustained increases of 4~6 and 
11.7 respectively compared to control injections (p 
< 0.01; Fig. 2). Larger doses of TRH, however, 
decreased C02 , production to a higher degree than 
0 2 consurnption. 
Locomotor activity (LA) after artifical CSF icv 
was 520 ± 172 counts/h, and increased to 717 ± 274 
(0.25nmol), 1620 ± 229 (1.25nmol), 1420 ± 448 
(2.5nmol), 1343 ± 248 (25nmol) and 1101 ± 391 
counts/h (50nmol) after icv injections of TRH. 
Although there appeared to be a dose-related 
increase of LA, especially after the injection of 
1.25 nmol TRH icv, no statistical significance was 
found when the TRH treatment was compared to 
vehicle injections using the Kruskal-Wallis test. 
Application of the Mann-Whitney-U test alone, 
however, yielded p values of 0.027 (1.25 nmol) and 
0.044 (25 nmol) when the treatment groups were 
compared to control injections. Since there exists 
an increased possibility of finding significant 
results when several tests are performed simul-
taneously, the adjustment of the statistical a-Ievel 
according to the Bonferroni procedure (17) or 
others is strongly advised (18). Since the calculated 
p values of both dosage groups do not reach or fall 
below the adjust a-value (a· = 0.01), both 
measurements have to be considered nonsignifi-
cant at a = 0.05. In order to resolve this 
controversy, another set of animals was prepared 
as described above. lnstead of consecutive, 
increasing doses of TRH, only one dose (1.25n-
mol, n = 6) was injected icv 1 h after the onset of 
the experiment. The resulting changes in ventila-
tor and locomotor activities were compared to 
single icv injections of 10,...1 artificial CSF (n = 5), 
which were performed in a similar manner. The 
t-test for independent samples was used for statis-
tical eval~ation. Relative respiratory minute 
volume (rV E was increased by 157o/o (p < 0.05) 
after 1.25 nmol TRH icv, while f ( curve areas: 2510 
± 183 vs. 1547 ± 460 respirations/h after CSF icv), 
rVT, and LA activity were not statistically 
different from CSF injections (Fig. 3). 
Discussion 
The present study demonstrates the effects of 
TRH on respiratory mechanics, gas exchange and 
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Fig. 2 Effects of TRH OIJ co2 production and 02 consump· 
tion (L'h] after consectuvie icv administration of increasing 
doses. Data are expressed as approximate curve areas of 
parameter changes over 1 h after each injection. • (p < 0.05) 
and •• (p < 0.01) denote statistical signiiicance, wben com-
pared to vehicle (artificial CSF) injcction (Kruskal-Wallis, n = 
5). 
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Fig. 3 Effect of a single dose of TRI-J (1.25nmol; n = 6) or 
lOf.LI artifical CSF (n = 5) icv on rVE [R], rVT (%] {left 
ordinate), and loqJmotor activity (LA, (counts/hj, right ord-
inate). Data for rVE and rVT are expressed as approximate 
curve areas of parameter changes over 1 h following the 
injection of 1.25nmol TRH or lOtLl CSF, whereas LA is 
derived by simple summation of LA counts ovcr the identical 
time period. 
• (p < 0.05, t-test) denotes statistical significance, when 
compared to CSF injections. 
locomotion after icv application in the conscious 
unrestrained rat. The results indicate that TRH in 
pico- to nanomole doses stimulates rVE due to an 
increase of both, fand rVT. While low doses of 
TRH appear to exclusively stimulate rVT, higher 
doses Iead to a decrease of rVt, combined with an 
enhanced f. Therefore the stimulatory action of 
TRH on rVE may be divided into a low dose 
component (0.25 to 1.25 nmoles icv.), driven 
primarily by an activation of VT, and a high dose 
element (2.5 to 50.0 nmoles icv.), in which the 
respiratory simulation is primarily due to an 
increased f. Simultaneaus with stimulation of 
respiratory mechanics, C02 production and Oz 
consumption were drastically increased after low 
doses of TRH icv with no further increment after 
higher doses. In fact, the increases of C02 produc-
tion and 0 2 consumption after higher doses (> 2.5 
nmol icv) were less than the corresponding 
changes induced by the 1.25 nmol dose, indicating 
a possible development of tachyphylaxis to this 
TRH effect. Moreover, TRH was unable to induce 
significant changes of LA within the tested range 
of TRH doses, suggesting the involvement of 
different mechanisms in the locomotor and 
ventilatory responses to TRH. 
Stimulatory effects of centrally administered 
TRH on cardiorespiratory functions have been 
reported in various species (6, 10, 11, 12). In the 
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anesthetized rat, TRH was shown to increase f 
after icv injection of pico- to nanomolar doses (6, 
10). This stimulatory effect on f was combined with 
a decrease of V T lea~ing to an either unchanged 
(10) or increased (6) VE. The underlying mode of 
action may involve an activation of inspiratory 
off·switch mechanisms in the brainstem, possibly 
due to an increased sensitivity to vagal afferent 
inputs (20). 
The results of the present study suggest that 
TRH stimulates ventilation unrelated to the state 
of consciousness of the animal. Moreover, a 
striking difference to previous sturlies using 
anesthetized animal preparations (6, 10) is the 
dose·related stimulation of VT, which appears to 
be primarily responsible for the elevation of VE 
over the low dose range. Interestingly, injection of 
a single dose (1.25 nmol) of TRH perrat produced 
a somewhat reduced effect on all measured para-
meters compared to the effects of the same dose 
administered after previous injections of CSF and 
0.25 nmol TRH. The mechanism underlying this 
phenomenon is unclear. Repeated icv injections of 
saline at hourly intervals appear to exert signifi-
cantly decre~sing responses of f, while no changes 
of VT or rVE could be detected (unpublished 
observation). This may reftect a behavioral habitu· 
ation to stress imposed by the handling of the 
animals du ring the injection itself. Since TRH was 
shown to enhance the reaction to stress paradigms, 
such as acoustic startle (19), previous administra-
tion of TRH may enhance the ventilatory 
responses to subsequent injections up to a degree 
where tachyphylaxis, presumably due to TRH 
receptor down-regulation exerts a counteracting 
effect. 
The discrete mechanisms involved in the effects 
of TRH on respiratory mechanics and gases are 
still unknown. They likely involve specific TRH 
receptors on brainstem nuclei participating in the 
central control of respiration, such as the dorsal 
motor nucleus of vagus and the nucleus tractus 
solitarii ( 4). This hypothesis is corroborated by 
sturlies showing that depletion of brain TRH 
content using the serotoninergic neurotoxin 5, 
7-dihydroxytryptamine, results in an upregulation 
of TRH receptors in brainstem and pons (21, 22) 
and an enhanced sensitivity to the respiratory 
stimulation by TRH (23). 
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The present results further indicate that TRH 
icv potently stimulates co2 production and 02 
consumption. The increase of co2 production 
may be accompanied by a decrease of P aC02 
leading to an increase of arterial pH as reported by 
Hedner et al. ( 6). However, no significant changes 
of Pa02 could be observed in this study. 
Additionally, TRH was shown to increase peri-
pheral metabolism by direct and indirect means. 
Grüfiths et al. (24) reported an activation of the 
metabolic rate of brown adipose tissue of rats 
which was presumably mediated by a Stimulation 
of sympathetic nerve activity (5). Moreover, the 
Stimulation of LA by TRH as previously shown by 
Andrews and Sahgal (7) may constitute an indirect 
mode of metabolic activation due to an increased 
peripheral energy consumption. lt, therefore, 
appears likely that the increases of C02 production 
and Oz consumption observed in the present study 
reflect a ventilatory compensation of enhanced 
peripheral metabolic demands. 
Although a reflex activation of central respira-
tory control mechanisms through a locomotion-
dependent increase of PaC02 leading to a Stimu-
lation ofVE may be possible, the mediation ofthe 
ventilatory effects of TRH by central TRH recep-
tors appears to be the pivotal mechanism of action 
as shown by the correlation of ventilatory 
responses of TRH with TRH receptor densities in 
CNS structures (23). Moreover, in anesthetized 
animals, TRH icv produces a Stimulation of venti-
lation accompanied by a decrease of p3C02 , 
emphasizing the centrat mode of action (6). It is 
yet unclear, however, to what extent peripheral 
metabolic demands inftuence the respiratory pat-
terns elicited by TRH. The present study revealed 
a dissociation of ventilatory and LA effects of 
TRH icv (Fig. 3). Thus, a single dose of TRH 
injected icv, clearly stimulated respiration as seen 
by an increase of rVE, while virtually no change of 
LA occurred. Moreover, the lowest dose of TRH 
used in this study (0.25nmol) was able to max-
imally stimulate Vr, C02 production, and 0 2 
consumption (Figs 1 & 2), while mean locomotor 
activity was increased by only 38o/o compared to 
icv injections of artifical CSF. Therefore, it 
appears unlikely that the ventilatory effects of 
TRH may primarily constitute a reflectory activa-
tion due to changes in metabolic homeostasis 
following an increased LA. Higher doses of TRH 
(10 to 100 JLg administered in single injections in 
2JLI volurnes), however, were shown to signifi-
cantly increase LA, possibly dependent on a 
diumal susceptibility rhythm (7). Therefore with 
administration of higher TRH doses, LA may 
become a significant factor in the stimulation of 
respiration via an increased muscular metabolism. 
In summary, the results of the present study 
indicate that TRH after icv administration in 
conscious rats stimulates ventilation and peri-
pheral metabolism as evidenced by an increase of 
co2 production and 02 consumption. The stimu-
latory effect of TRH appears to result from an 
activation of mechanisms involved in the central 
control of ventilation. Furthermore, the anesthe-
sia-reversing properties of TRH may be of neglig-
ible importance in eliciting the ventilatory effects 
of TRH in studies using anesthetized animals. 
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